Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 8,421	$ 3,684	$ 19,680	$ 10,332
General and administrative	13,308	7,004	40,305	11,509
Total operating expenses	21,729	10,688	59,985	21,841
Loss from operations	(21,729)	(10,688)	(59,985)	(21,841)
Other income (expense):
Change of fair value of Sponsor Earn-Out liability, net	(4,870)		16,400
Interest income	1,972	160	2,460	163
Other income (expense), net	420	(94)	(911)	694
Total other income (expense), net	(2,478)	66	17,949	857
Loss before income taxes	(24,207)	(10,622)	(42,036)	(20,984)
Provision for income taxes	(121)	(3)	(310)	(22)
Net loss	(24,328)	(10,625)	(42,346)	(21,006)
Other comprehensive loss:
Foreign currency translation adjustment	(1,194)	(23)	(2,462)	48
Total comprehensive loss	$ (25,522)	$ (10,648)	$ (44,808)	$ (20,958)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.08)	$ (0.17)	$ (0.15)	$ (0.35)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.08)	$ (0.17)	$ (0.15)	$ (0.35)
Weighted-average shares outstanding, basic (in shares)	311,680,656	60,861,409	280,859,250	60,808,744
Weighted-average shares outstanding, diluted (in shares)	311,680,656	60,861,409	280,859,250	60,808,744